BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1458970)

  • 1. Anisodamine inhibits acetylcholine-induced endothelium-dependent relaxation of canine femoral artery.
    Guo HY; Loren RR; Vanhutte PM
    Chin Med J (Engl); 1992 Aug; 105(8):666-70. PubMed ID: 1458970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biphasic release of endothelium-derived relaxing factor(s) by acetylcholine from perfused canine femoral arteries. Characterization of muscarinic receptors.
    Rubanyi GM; McKinney M; Vanhoutte PM
    J Pharmacol Exp Ther; 1987 Mar; 240(3):802-8. PubMed ID: 2435886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular actions of TA 3090, a novel analog of diltiazem: interaction with endothelium-dependent relaxation in canine femoral and coronary arteries.
    Rubanyi G; Iqbal A; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1991 Nov; 259(2):639-42. PubMed ID: 1941612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity of endothelium-dependent responses to acetylcholine in canine femoral arteries and veins. Separation of the role played by endothelial and smooth muscle cells.
    Rubanyi GM; Vanhoutte PM
    Blood Vessels; 1988; 25(2):75-81. PubMed ID: 3257889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between endothelium-derived relaxing factors in the rat hepatic artery: focus on regulation of EDHF.
    Zygmunt PM; Plane F; Paulsson M; Garland CJ; Högestätt ED
    Br J Pharmacol; 1998 Jul; 124(5):992-1000. PubMed ID: 9692786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereoselective effect of diltiazem on endothelium-dependent relaxations in canine femoral arteries.
    Rubanyi GM; Hoeffner U; Schwartz A; Vanhoutte PM
    J Pharmacol Exp Ther; 1988 Jul; 246(1):60-4. PubMed ID: 2455796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phorbol dibutyrate inhibits release and action of endothelium-derived relaxing factor(s) in canine blood vessels.
    Rubanyi GM; Desiderio D; Luisi A; Johns A; Sybertz EJ
    J Pharmacol Exp Ther; 1989 Jun; 249(3):858-63. PubMed ID: 2499677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anisodamine inhibits non-selectively muscarinic receptors in isolated canine veins.
    Guo HY; Lorenz RR; Vanhoutte PM
    Chin Med J (Engl); 1992 Jan; 105(1):5-10. PubMed ID: 1576871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potassium-free solution prevents the action but not the release of endothelium-derived relaxing factor.
    Rubanyi GM; Vanhoutte PM
    Eur J Pharmacol; 1988 Jan; 145(3):351-5. PubMed ID: 3258243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitors of acyl-coenzyme A:lysolecithin acyltransferase activate the production of endothelium-derived vascular relaxing factor.
    Förstermann U; Goppelt-Strübe M; Frölich JC; Busse R
    J Pharmacol Exp Ther; 1986 Jul; 238(1):352-9. PubMed ID: 3487639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The endothelium and vascular effects of the ACE inhibitor trandolaprilat.
    Vidal M; Joly G; Mombouli JV; Boulanger CM; Vanhoutte PM
    J Cardiovasc Pharmacol; 1994; 23 Suppl 4():S1-5. PubMed ID: 7527094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that mechanisms dependent and independent of nitric oxide mediate endothelium-dependent relaxation to bradykinin in human small resistance-like coronary arteries.
    Kemp BK; Cocks TM
    Br J Pharmacol; 1997 Mar; 120(5):757-62. PubMed ID: 9138678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evidence that endothelium-derived relaxing factor is nitric oxide: use of pyrogallol and superoxide dismutase to study endothelium-dependent and nitric oxide-elicited vascular smooth muscle relaxation.
    Ignarro LJ; Byrns RE; Buga GM; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jan; 244(1):181-9. PubMed ID: 2826766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelial mediators of the acetylcholine-induced relaxation of the rat femoral artery.
    Leung HS; Leung FP; Yao X; Ko WH; Chen ZY; Vanhoutte PM; Huang Y
    Vascul Pharmacol; 2006 May; 44(5):299-308. PubMed ID: 16527547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms underlying endothelium-dependent, nitric oxide- and prostanoid-independent relaxation in monkey and dog coronary arteries.
    Fujioka H; Ayajiki K; Shinozaki K; Toda N; Okamura T
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):488-95. PubMed ID: 12382080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of lumbar sympathectomy on the properties of both endothelium and smooth muscle cells of the canine femoral artery and autogenous vein grafts under poor runoff conditions.
    Funahashi S; Komori K; Itoh H; Okadome K; Sugimachi K
    J Surg Res; 1996 Aug; 64(2):184-9. PubMed ID: 8812631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying endothelium-independent relaxation by acetylcholine in canine retinal and cerebral arteries.
    Toda N; Zhang JX; Ayajiki K; Okamura T
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1507-12. PubMed ID: 7562527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. One-hour exposure to University of Wisconsin solution does not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries.
    Ekin ST; Pearson PJ; Evora PR; Schaff HV
    J Heart Lung Transplant; 1993; 12(4):624-33. PubMed ID: 8369325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endothelium-dependent relaxing factors do not affect the smooth muscle of portal-mesenteric veins.
    Feletou M; Hoeffner U; Vanhoutte PM
    Blood Vessels; 1989; 26(1):21-32. PubMed ID: 2785422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.